Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models
Cancer Genomics - Proteomics · 2025-03 · 22 (2) · 136-165
DOI: 10.21873/cgp.20494 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 24.02.2025. Verfasst von Ulrich H Weidle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de fabian.birzele@roche.com. Hauptthemen laut MEDLINE: RNA, Circular, Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany; weidle49@t-online.de fabian.birzele@roche.com.
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland weidle49@t-online.de fabian.birzele@roche.com.
Zitieren
APA
Weidle, U. H., & Birzele, F. (2025). Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models. Cancer Genomics - Proteomics, 22(2), 136-165. https://doi.org/10.21873/cgp.20494
Vancouver
Weidle UH, Birzele F. Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models. Cancer Genomics - Proteomics. 2025;22(2):136-165. doi:10.21873/cgp.20494
BibTeX
@article{Weidle2025,
author = {Weidle, Ulrich H and Birzele, Fabian},
title = {Prostate Cancer: De-regulated Circular RNAs With Efficacy in Preclinical In Vivo Models},
journal = {Cancer Genomics - Proteomics},
year = {2025},
volume = {22},
number = {2},
pages = {136--165},
doi = {10.21873/cgp.20494}
}
EUVIMED